Simone NEGRINI

Associate Professor

University of Genoa

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Simone Negrini is an Associate Professor at the University of Genoa, Italy. His research interests focus on systemic lupus erythematosus, asthma, and systemic sclerosis, as evidenced by his recent publications exploring the impacts of smoking and steroid use on antibody responses, and the development of networks for systemic diseases. Dr. Negrini also investigates sex-based differences in asthma and clinical characteristics of systemic illnesses across diverse populations.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (18)

Roberto G Carbone MD FCCP FRSM

Professor of Medicine

University of Genoa

ITALY

Simone NEGRINI

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

The LUNET Project: Developing the Italian Systemic Erythematous Lupus Network

Impact of Smoking, Steroid Use and Immunosuppression on Anti-dsDNA Antibodies in Systemic Lupus Erythematosus

Sex-Based Differences in Asthma: Pathophysiology, Hormonal Influence, and Genetic Mechanisms

Clinical Characteristics of Systemic Lupus Erythematosus in Caucasians and Latin American Hispanics: Data from a Single Tertiary Center

Expression of epidermal growth factor receptor (EGFR) in systemic sclerosis patients (SSc) and gastro-oesophageal reflux disease (GORD)

Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS)

Early COPD diagnosis and treatment: A case report

Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in Haemodialysis-Treated Patients: Time for a Treatment Shift?

New York Heart Association class and pulmonary artery pressure as prognostic factors of interstitial lung disease survival

Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort

Turning tables: a war-like approach to neurosurgical emergencies in the COVID-19 era

Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)

Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in Haemodialysis-Treated Patients: Time for a Treatment Shift?

Sjögren’s syndrome: a systemic autoimmune disease

Recurrence of COVID-19 related symptoms and viral detection in a patient discharged after complete recovery and test negativization

Collaborators (18)

Roberto G Carbone MD FCCP FRSM

Angelo Vacca

Francesco Ciccia

Elena Bartoloni

Vito Racanelli

Francesco PUPPO

franco franceschini

Giovanna Cuomo

Carlo Selmi

Andrea Doria

Laura ANDREOLI

Maurizio Rossini

Mariele Gatto

Mario DI GIOACCHINO

Francesca Wanda Rossi

Pasquale Esposito

Douglas Veale

Marcello Govoni

Make your next move.